Voravit Ratanatharathorn

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

Anas Younes, Armando Santoro, Margaret A. Shipp et al. · The Lancet Oncology · 2016 · 924 citations · Full text

Medicine, Hematology, Oncology +16

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

Craig Kollman, Craig Howe, Claudio Anasetti et al. · Blood · 2001 · 702 citations · Full text

Medicine, Hematology, Immunology +17

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

Richard A. Nash, Joseph H. Antin, Chatchada Karanes et al. · PubMed · 2000 · 591 citations

Life Sciences, Hematology, Immunology +13

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

Voravit Ratanatharathorn, Richard A. Nash, Donna Przepiorka et al. · PubMed · 1998 · 568 citations

Life Sciences, Immunology, Pharmacology +16

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

David W. Denning, Kieren A. Marr, W. Lau et al. · Journal of Infection · 2006 · 294 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17